Karen L. Zaderej - 16 Mar 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
CEO, Director
Signature
/s/ Karen Zaderej
Issuer symbol
AXGN
Transactions as of
16 Mar 2022
Net transactions value
$0
Form type
4
Filing time
18 Mar 2022, 16:12:14 UTC
Previous filing
17 Feb 2022
Next filing
13 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $0 +25,950 +2.8% $0.000000 966,333 16 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Options Exercise $0 -25,950 -50% $0.000000 25,950 16 Mar 2022 Common Stock 25,950 Direct F2, F3
transaction AXGN Restricted Stock Units Award $0 +169,694 $0.000000 169,694 16 Mar 2022 Common Stock 169,694 Direct F2, F4
transaction AXGN Employee Stock Option (right to purchase) Award $0 +317,185 $0.000000 317,185 16 Mar 2022 Common Stock 317,185 $10.25 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects the number of restricted stock units that became vested as of March 16, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F3 All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
F4 All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
F5 The exercise price of $10.25 represents a 25% premium over the fair market value of Axogen common stock on the date of the grant.
F6 All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 16, 2023 and on each anniversary thereafter.